Professor Pierre Amarenco

Pierre Amarenco is Professor of Neurology at Paris University, Paris, France. He is chair and funder of the department of Neurology and Stroke Center as well as of SOS-TIA clinic at Bichat university hospital in Paris. He is co-chair of the “Clinical research in atherothrombosis” group at INSERM LVTS-1148 unit. Pierre Amarenco’s research field is understanding and preventing stroke. He has published more than 400 research papers, reviews and book chapters; he particularly contributed to the descriptions of cerebellar infarctions, aortic arch atherosclerosis in relation with stroke, risk factors for stroke (including genetic and metabolic risk factors), and participated as a member or chair of Executive or Steering Committees of many clinical trials using antithrombotic agents, lipid-modifying agents (including SPARCL trial, Treat Stroke to Target Trial, XANTUS, SOCRATES, THALES, SPIRE and PROMINENT trials) or acute revascularization (RECANALISE study), and is leading the TIAregistry